INDEPENDENT VERDICT
Redemption MRE Income Fund LLC is a Texas medical-real-estate vehicle backed by a sponsor with a visible operating history, identified leadership, a functioning investor portal and specific healthcare-property targets rather than an anonymous Form D issuer. The September 11, 2026 amendment reports a $50 million Rule 506(c) offering, $3,624,652 sold, five investors and a $100,000 minimum, up from $0 sold in the original September 2025 filing. Christian Catron, Eric Acheson and Arthur Johnson appear as current directors in the latest public record, while Michael Euperio appeared in the original filing. The sponsor, Redeem Investments, publicly describes a focused strategy of acquiring medical and dental real estate—ambulatory surgical centers, clinics, urgent-care facilities, dialysis or infusion centers, rehab and senior-care properties—primarily in Sunbelt markets under long-duration triple-net lease structures. The strongest public evidence therefore supports the existence of a real medical-real-estate operating platform. What remains less clear is how the current $3.62 million of reported investor subscriptions maps to the individual properties being promoted, how much acquisition debt is used at the fund level, and how the sponsor's projected returns compare with realized audited results.
The Form D progression is straightforward but important. Redemption MRE Income Fund LLC, CIK 0002084967, was organized in Texas in 2025 and uses 1779 Wells Branch Parkway, Suite 110B-371, Austin, Texas 78728 as its principal address. The original September 24, 2025 filing showed a $50 million offering with $0 sold and no first sale yet reported. The September 11, 2026 amendment now reports a September 30, 2025 first sale, $3,624,652 sold and $46,375,348 remaining, meaning only about 7.25% of the stated offering had been subscribed by the amendment date. Five investors imply an average subscription of approximately $724,930 if commitments were equal, although actual checks may vary substantially. The offering relies on Rule 506(c), so purchasers must be accredited investors and the issuer must take reasonable steps to verify that status. The fund reports no sales commissions or finder fees, offers equity and pooled-investment-fund interests, and is categorized within the SEC's commercial real-estate grouping rather than as a hedge fund, venture-capital fund or private-equity fund.
The investment thesis is considerably more specific than the SEC form itself. Redeem Investments says it targets net-leased medical real estate with healthcare operators whose specialties have durable demand, generally seeking properties where total project cost is below replacement cost, stabilized rent is below roughly 15% of tenant revenue, acquisition cap rates exceed 8%, and long-term NNN leases shift taxes, insurance, maintenance and often capital expenditure obligations to the tenant. The current investor materials describe 10- to 30-year absolute NNN leases, an approximate 8% cash-on-cash target paid quarterly, a 13–16% target IRR and roughly 1.8x equity multiple, with upside cases marketed above those figures. Those are sponsor projections, not SEC-verified returns. The same materials describe a roughly five-year hold period, immediate or near-immediate cash flow after acquisition, tax deductions potentially enhanced by depreciation and cost segregation, and a plan to exit either through portfolio sales to healthcare REITs or individual property dispositions. The economics therefore depend on several variables the promotional headline does not fully capture: purchase basis, tenant credit, lease duration, debt cost, residual property value and whether exit cap rates remain favorable.
The initial asset descriptions provide a much more concrete view of the portfolio. Redeem's offering materials identify a three-property Multi-Specialty Holdings dental portfolio across Florida, Tennessee and Arizona with 15-year absolute NNN leases and claim approximately $1.6 million of built-in equity at acquisition. The sponsor also identifies the McDowell Ambulatory Surgical Center in Phoenix, a 32,806-square-foot surgical facility with a 30-year absolute NNN lease, and claims roughly $5 million of acquisition-day equity creation. Redeem has separately promoted the Phoenix asset as being near Banner University Medical Center and has discussed additional medical-real-estate acquisitions through its public channels. A webinar associated with the MRE Income Fund states that the first two asset groups together represented roughly $7 million of claimed built-in equity. These figures are economically important but remain sponsor-generated estimates; public records reviewed do not independently establish the appraisal methodology, acquisition price, debt allocated to each asset or whether all promoted properties are currently owned directly by Redemption MRE Income Fund LLC rather than by parallel property entities.
The sponsor history also explains why this fund should not be analyzed as Redeem's first real-estate vehicle. Christian Catron, Redeem's President and CEO, publicly describes roughly two decades of healthcare-industry experience before focusing on commercial real estate; the company says its current strategy is exclusively medical real estate. Before the MRE Income Fund, Redeem marketed the Redemption ARMOR Fund—Adaptive Reuse & Medical Office Realty—as a Rule 506(c) vehicle focused on acquiring underutilized commercial buildings and converting or repositioning them into medical-office, hospitality and related uses. Public sponsor posts identified projects such as a Temple office-to-Courtyard Marriott conversion, a DeSoto hotel, an 80,000-square-foot San Antonio medical-office/coworking property and ambulatory surgical-center opportunities in Abilene and Marble Falls. Michael Euperio publicly described San Antonio office assets as seed investments for that ARMOR strategy. This earlier fund history is relevant because it shows continuity in the sponsor's broader value-creation approach—buy below replacement cost, reposition where necessary, then use healthcare or other durable-use tenants—but the prior ARMOR assets should not be treated as holdings of the 2025 MRE Income Fund unless ownership records or current fund documents say so.
CORE SEC AND FUND FACTS
Legal Name: Redemption MRE Income Fund LLC CIK: 0002084967 Jurisdiction: Texas Year Organized: 2025 Principal Address: 1779 Wells Branch Pkwy, Ste. 110B-371, Austin, TX 78728 Phone: 512-269-0041 Original Form D: September 24, 2025 Latest Form D/A: September 11, 2026 First Sale: September 30, 2025 Exemption: Rule 506(c) Security Types: Equity; Pooled Investment Fund Interests Industry: Commercial Real Estate Offering Target: $50,000,000 Amount Sold: $3,624,652 Amount Remaining: $46,375,348 Investors: 5 Minimum Investment: $100,000 Approximate Target Subscribed: 7.25% Approximate Average Investment if Equal: $724,930 Sales Commissions: $0 Finders' Fees: $0
Current Related Persons in 2026 Filing: Christian Catron Eric Acheson Arthur Johnson
Original 2025 Filing Also Listed: Michael Euperio
SPONSOR AND STRATEGY EVIDENCE
Sponsor Brand: Redeem Investments Founder / CEO: Christian Catron Headquarters: Austin, Texas Core Focus: Medical real estate Primary Markets: U.S. Sunbelt Target Property Types: Ambulatory surgical centers, medical/dental/veterinary clinics, urgent-care and emergency centers, infusion and dialysis facilities, rehab hospitals, assisted living and memory-care assets Preferred Lease Structure: Long-term NNN / absolute NNN Public Acquisition Criteria: Below-replacement-cost basis, rent supportability relative to tenant revenue, long lease duration and attractive acquisition cap rates Publicly Marketed Hold Period: Approximately 5 years Publicly Marketed Cash Yield: Approximately 8% Publicly Marketed Target IRR: 13–16% Publicly Marketed Target Equity Multiple: Approximately 1.8x Important Qualification: All return figures are sponsor projections, not SEC-verified or guaranteed results.
IDENTIFIED INITIAL ASSET MATERIALS
Multi-Specialty Holdings Dental Portfolio: 3 properties Markets: Florida, Tennessee and Arizona Lease Structure: 15-year absolute NNN Sponsor-Claimed Built-In Equity: Approximately $1.6 million
McDowell Ambulatory Surgical Center: Location: Phoenix, Arizona Size: 32,806 square feet Lease Structure: 30-year absolute NNN Sponsor-Claimed Built-In Equity: Approximately $5 million
Combined Sponsor-Claimed Built-In Equity Across Initial Assets: Approximately $7 million
Important Limitation: Public materials reviewed do not independently verify the appraisals, acquisition basis, leverage or whether every promoted property is directly held by Redemption MRE Income Fund LLC.
PRIOR REDEEM FUND HISTORY
Prior Vehicle: Redemption ARMOR Fund
ARMOR Meaning: Adaptive Reuse & Medical Office Realty
Exemption: Rule 506(c)
Public Strategy: Acquire underutilized commercial real estate below replacement cost and convert or reposition assets into higher-value uses such as medical-office or hospitality properties.
Publicly Discussed Prior Projects: Temple, Texas office-to-Courtyard Marriott conversion DeSoto, Texas hotel San Antonio 80,000-square-foot hybrid medical-office/coworking property Abilene ambulatory surgical center opportunity Marble Falls ambulatory surgical center opportunity
Research Treatment: These projects establish sponsor operating history but should not be attributed to the current MRE Income Fund without direct ownership evidence.
WHAT STILL REQUIRES INDEPENDENT VERIFICATION
Current Fund NAV: Not publicly verified Current Gross Property Value: Not publicly verified Fund-Level Debt: Not disclosed in Form D Property-Level Debt: Not fully mapped publicly Loan-to-Value: Not publicly confirmed Interest Rates: Not publicly confirmed Debt Maturities: Not publicly confirmed Tenant Financial Statements: Not public Tenant Credit Ratings: Not established for every property Current Occupancy: Not fully disclosed Rent Coverage Ratios: Not independently verified Appraisals Supporting "Built-In Equity": Not public Audited Fund Performance: Not public Realized Fund IRR: Not public Management Fee: Requires PPM review Carried Interest / Promote: Requires PPM review Acquisition Fee: Requires PPM review Asset-Management Fee: Requires PPM review Disposition Fee: Requires PPM review Fund Auditor: Not identified in Form D Fund Administrator: Not identified in Form D Custodian: Not identified in Form D
INDEPENDENT ASSESSMENT
Redemption MRE Income Fund has a materially stronger public operating trail than a generic private real-estate issuer. The SEC record confirms a real $50 million 506(c) offering that progressed from $0 sold in September 2025 to $3.624652 million from five investors by September 2026. Redeem Investments has a functioning website and investor portal, named leadership, a clearly articulated medical-real-estate strategy and specific promoted assets rather than only abstract marketing language.
The fund's most distinctive feature is its dependence on long-duration healthcare leases rather than ordinary apartment or office value-add. Absolute NNN leases can reduce landlord operating expense exposure, but they concentrate risk in tenant credit, healthcare-operator performance and residual real-estate value. A 20- or 30-year lease is only as strong as the tenant and guarantor behind it, while a surgical center or specialty clinic can be more difficult to re-tenant than a generic commercial building if an operator fails. Investors therefore need to assess lease guarantees, tenant financials, rent coverage and healthcare-market demand rather than relying solely on the term "recession-resistant."
The second major diligence issue is leverage and appraisal support. Redeem repeatedly emphasizes acquisition below replacement cost and millions of dollars of "built-in equity," but those figures should be reconciled to third-party appraisals, closing statements and debt documents. If acquisition debt is substantial, apparent day-one equity based on appraisal value may not translate into the same downside protection for fund investors. Likewise, advertised 13–16% IRR and 8% cash yield are forward-looking targets that depend on financing costs, rent collections, tenant solvency, depreciation assumptions and eventual exit pricing.
The strongest current conclusion is that Redemption MRE Income Fund is a verifiable medical-real-estate offering tied to an identifiable Austin sponsor with prior commercial-real-estate activity and a specific NNN healthcare strategy. The SEC filing verifies the securities raise; the sponsor materials identify the intended investment model and initial assets; neither source independently verifies future returns, current NAV or claimed built-in equity. Those distinctions should remain explicit in any investor-facing review.
Form D is a notice of an exempt securities offering and does not constitute SEC approval or endorsement of Redemption MRE Income Fund, Redeem Investments, Christian Catron, Eric Acheson, Arthur Johnson, Michael Euperio or any underlying medical property. Projected cash yields, IRRs, equity multiples and built-in-equity figures are sponsor estimates and should not be presented as realized or guaranteed performance.